Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImageneBio (IMA) EBT Margin (2020 - 2024)

Historic EBT Margin for ImageneBio (IMA) over the last 5 years, with Q3 2024 value amounting to 90.94%.

  • ImageneBio's EBT Margin rose 13726000.0% to 90.94% in Q3 2024 from the same period last year, while for Dec 2024 it was 1437.03%, marking a year-over-year decrease of 6911700.0%. This contributed to the annual value of 745.94% for FY2023, which is 3056500.0% down from last year.
  • As of Q3 2024, ImageneBio's EBT Margin stood at 90.94%, which was up 13726000.0% from 2981.94% recorded in Q4 2023.
  • In the past 5 years, ImageneBio's EBT Margin ranged from a high of 13.83% in Q4 2021 and a low of 40081.54% during Q4 2020
  • In the last 5 years, ImageneBio's EBT Margin had a median value of 279.79% in 2021 and averaged 3162.43%.
  • Per our database at Business Quant, ImageneBio's EBT Margin soared by 400953700bps in 2021 and then plummeted by -50191300bps in 2022.
  • Quarter analysis of 5 years shows ImageneBio's EBT Margin stood at 40081.54% in 2020, then soared by 100bps to 13.83% in 2021, then tumbled by -1970bps to 258.66% in 2022, then tumbled by -1053bps to 2981.94% in 2023, then surged by 97bps to 90.94% in 2024.
  • Its last three reported values are 90.94% in Q3 2024, 2981.94% for Q4 2023, and 1463.54% during Q3 2023.